Animal Models of Hepatitis B Virus Infection–Success, Challenges, and Future Directions
Chronic hepatitis B virus (HBV) infection affects more than 250 million people worldwide, which greatly increases the risk for terminal liver diseases, such as liver cirrhosis and hepatocellular carcinoma (HCC). Even though current approved antiviral therapies, including pegylated type I interferon...
Main Authors: | Yongzhen Liu, Stephanie Maya, Alexander Ploss |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/5/777 |
Similar Items
-
Conversion of hepatitis B virus relaxed circular to covalently closed circular DNA is supported in murine cells
by: Lei Wei, et al.
Published: (2022-09-01) -
Animal Models Used in Hepatitis C Virus Research
by: Keith A. Berggren, et al.
Published: (2020-05-01) -
Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus
by: Jenna M Gaska, et al.
Published: (2019-05-01) -
Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
by: Stephanie Maya, et al.
Published: (2023-08-01) -
Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future
by: Xiaonan Zhang, et al.
Published: (2021-07-01)